Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases

Hisato Igarashi, Tetsuhide Ito, takamasa ono, Taichi Nakamura, Nao Fujimori, Yusuke Niina, Masayuki Hijioka, Masahiko Uchida, Ringaku Lee, Risa Iwao, Kazuhiko Nakamura, Kazuhiro Kotoh, Ryoichi Takayanagi

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.

元の言語英語
ページ(範囲)274-279
ページ数6
ジャーナルJournal of Digestive Diseases
13
発行部数5
DOI
出版物ステータス出版済み - 5 1 2012

Fingerprint

Immunoglobulins
Immunoglobulin G
Serum
Sialadenitis
Steroids
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Gastroenterology

これを引用

Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases. / Igarashi, Hisato; Ito, Tetsuhide; ono, takamasa; Nakamura, Taichi; Fujimori, Nao; Niina, Yusuke; Hijioka, Masayuki; Uchida, Masahiko; Lee, Ringaku; Iwao, Risa; Nakamura, Kazuhiko; Kotoh, Kazuhiro; Takayanagi, Ryoichi.

:: Journal of Digestive Diseases, 巻 13, 番号 5, 01.05.2012, p. 274-279.

研究成果: ジャーナルへの寄稿記事

Igarashi, H, Ito, T, ono, T, Nakamura, T, Fujimori, N, Niina, Y, Hijioka, M, Uchida, M, Lee, R, Iwao, R, Nakamura, K, Kotoh, K & Takayanagi, R 2012, 'Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases', Journal of Digestive Diseases, 巻. 13, 番号 5, pp. 274-279. https://doi.org/10.1111/j.1751-2980.2012.00583.x
Igarashi, Hisato ; Ito, Tetsuhide ; ono, takamasa ; Nakamura, Taichi ; Fujimori, Nao ; Niina, Yusuke ; Hijioka, Masayuki ; Uchida, Masahiko ; Lee, Ringaku ; Iwao, Risa ; Nakamura, Kazuhiko ; Kotoh, Kazuhiro ; Takayanagi, Ryoichi. / Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases. :: Journal of Digestive Diseases. 2012 ; 巻 13, 番号 5. pp. 274-279.
@article{e6e05456cca746fd939ab5f45fcbedb0,
title = "Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases",
abstract = "Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.",
author = "Hisato Igarashi and Tetsuhide Ito and takamasa ono and Taichi Nakamura and Nao Fujimori and Yusuke Niina and Masayuki Hijioka and Masahiko Uchida and Ringaku Lee and Risa Iwao and Kazuhiko Nakamura and Kazuhiro Kotoh and Ryoichi Takayanagi",
year = "2012",
month = "5",
day = "1",
doi = "10.1111/j.1751-2980.2012.00583.x",
language = "English",
volume = "13",
pages = "274--279",
journal = "Journal of Digestive Diseases",
issn = "1751-2972",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases

AU - Igarashi, Hisato

AU - Ito, Tetsuhide

AU - ono, takamasa

AU - Nakamura, Taichi

AU - Fujimori, Nao

AU - Niina, Yusuke

AU - Hijioka, Masayuki

AU - Uchida, Masahiko

AU - Lee, Ringaku

AU - Iwao, Risa

AU - Nakamura, Kazuhiko

AU - Kotoh, Kazuhiro

AU - Takayanagi, Ryoichi

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.

AB - Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.

UR - http://www.scopus.com/inward/record.url?scp=84859829513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859829513&partnerID=8YFLogxK

U2 - 10.1111/j.1751-2980.2012.00583.x

DO - 10.1111/j.1751-2980.2012.00583.x

M3 - Article

VL - 13

SP - 274

EP - 279

JO - Journal of Digestive Diseases

JF - Journal of Digestive Diseases

SN - 1751-2972

IS - 5

ER -